Sucampo Pharmaceuticals Stock Shares Outstanding
Sucampo Pharmaceuticals fundamentals help investors to digest information that contributes to Sucampo Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Sucampo Stock. The fundamental analysis module provides a way to measure Sucampo Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Sucampo Pharmaceuticals stock.
Sucampo |
Sucampo Pharmaceuticals Company Shares Outstanding Analysis
Sucampo Pharmaceuticals' Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Sucampo Pharmaceuticals Shares Outstanding | 47.09 M |
Most of Sucampo Pharmaceuticals' fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Sucampo Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
CompetitionBased on the latest financial disclosure, Sucampo Pharmaceuticals has 47.09 M of shares currently outstending. This is 73.92% lower than that of the sector and 52.57% lower than that of the Shares Outstanding industry. The shares outstanding for all United States stocks is 91.76% higher than that of the company.
Sucampo Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Sucampo Pharmaceuticals' direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Sucampo Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Sucampo Pharmaceuticals by comparing valuation metrics of similar companies.Sucampo Pharmaceuticals is currently under evaluation in shares outstanding category among related companies.
Sucampo Fundamentals
| Return On Equity | 14.16 | |||
| Return On Asset | 0.0296 | |||
| Profit Margin | 7.80 % | |||
| Operating Margin | 30.77 % | |||
| Current Valuation | 1.05 B | |||
| Shares Outstanding | 47.09 M | |||
| Shares Owned By Insiders | 35.13 % | |||
| Shares Owned By Institutions | 82.48 % | |||
| Number Of Shares Shorted | 4.59 M | |||
| Price To Earning | (2.77) X | |||
| Price To Book | 21.08 X | |||
| Price To Sales | 3.38 X | |||
| Revenue | 250.47 M | |||
| Gross Profit | 154.05 M | |||
| EBITDA | 107.24 M | |||
| Net Income | (150.89 M) | |||
| Cash And Equivalents | 75.04 M | |||
| Cash Per Share | 1.62 X | |||
| Total Debt | 293.54 M | |||
| Debt To Equity | 740.60 % | |||
| Current Ratio | 5.11 X | |||
| Book Value Per Share | 2.26 X | |||
| Cash Flow From Operations | 28.51 M | |||
| Short Ratio | 9.78 X | |||
| Earnings Per Share | (3.37) X | |||
| Price To Earnings To Growth | 5.30 X | |||
| Number Of Employees | 139 | |||
| Beta | 0.58 | |||
| Market Capitalization | 847.54 M | |||
| Total Asset | 457.18 M | |||
| Retained Earnings | 24.37 M | |||
| Working Capital | 163.23 M | |||
| Current Asset | 251.36 M | |||
| Current Liabilities | 88.13 M | |||
| Z Score | 1.2 |
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in population. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Sucampo Stock
If you are still planning to invest in Sucampo Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Sucampo Pharmaceuticals' history and understand the potential risks before investing.
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance |